US70465T1079
US70465T1079
PDS Biotechnology Corporation
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 100.01M EUR | 49.27M EUR | 33.77M EUR | 42.26M EUR |
Enterprise Value | 55.86M EUR | 48.03M EUR | 27.97M EUR | 32.47M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -4x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | -- | -- | 8.67x | 4.57x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -2.01x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -13.76% | -34.06% | -68.38% | -44.3% |